NASDAQ: COSMCosmos Health Inc Stock
$0.51-0.02 (-3.77%)
Updated Apr 24, 2024
COSM Price
$0.51
Fair Value Price
N/A
Market Cap
$6.84M
52 Week Low
$0.47
52 Week High
$4.05
P/E
-0.12x
P/B
0.15x
P/S
0.4x
PEG
N/A
Dividend Yield
N/A
Revenue
$49.59M
Earnings
-$15.61M
Gross Margin
7.2%
Operating Margin
-26.47%
Profit Margin
-86.5%
Debt to Equity
0.61
Operating Cash Flow
-$27M
Beta
0.2
Next Earnings
May 15, 2024
Ex-Dividend
N/A
Next Dividend
N/A
COSM Overview
Cosmos Holdings Inc. offers branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care, baby products, and medical devices. It serves wholesale pharmaceutical distributors and independent retail pharmacies in the U.S., U.K., and Greece. Cosmos Holdings was incorporated in 2009 and is headquartered in Chicago, IL.
Zen Score
–
Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how COSM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
COSM is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
COSM is good value based on its book value relative to its share price (0.15x), compared to the US Drug Manufacturers - Specialty & Generic industry average (2.06x)
P/B vs Industry Valuation
COSM is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more COSM due diligence checks available for Premium users.
Be the first to know about important COSM news, forecast changes, insider trades & much more!
COSM News
Valuation
COSM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.12x
Industry
47.66x
Market
41.27x
COSM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.15x
Industry
2.06x
COSM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
COSM's financial health
Profit margin
Revenue
$12.8M
Net Income
-$3.3M
Profit Margin
-26.2%
COSM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
COSM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$71.5M
Liabilities
$27.0M
Debt to equity
0.61
COSM's short-term assets ($46.49M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
COSM's short-term assets ($46.49M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
COSM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
COSM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$4.5M
Investing
-$2.0M
Financing
$6.3M
COSM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
COSM vs Pharmaceutical Stocks
Cosmos Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.